Seretide 50 Evohaler 25 microgram / 50 microgram / dose pressurised inhalation, suspension
- Licence status
- Withdrawn: 31/01/2022
- Active substances
- SALMETEROL XINAFOATE, Fluticasone propionate
- Dosage Form
- Pressurised inhalation, suspension
- Licence number
- PPA0465/091/004
- Licence holder
- PCO Manufacturing Ltd.
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, R03AK06 salmeterol and fluticasone
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA1077/046/004.
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 06/02/2004